US Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

US Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • July 2019 •
  • 620 pages •
  • Report ID: 5797536 •
  • Format: PDF
US Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Highlights

  • Comprehensive 620-page analysis of the US tumor marker testing market.
  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

    Contains 620 pages and 103 tables


    Companies Profiled
    Competitive Assessments

    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Cepheid
    - Diamedix
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujirebio
    - Grifols
    - GSK Biologicals
    - Hologic
    - Leica Biosystems
    - Lonza
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - SeraCare
    - Siemens Healthineers
    - Takara Bio
    - Thermo Fisher
    - Wako